No Data
No Data
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
Monday Market Mixed Before Crazy, Piovitol Week | Live Stock
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $120 to $125
Weekly Buzz: Magnificent Mix of Market Reactions
November Starts with a Climb to end Tough Week | Wall Street Today
Merck Price Target Cut to $110.00/Share From $125.00 by Wells Fargo